Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mariusz Shrestha

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Clinical Epigenetics|April 10, 2026
Deciphering epigenetic crosstalk in multiple myeloma pathogenesis and treatmentShamila D Alipoor, Mariusz Shrestha, Aijun Liu, et al.
Oncogenesis|May 25, 2023
CDK4/6 inhibitors and the pRB-E2F1 axis suppress PVR and PD-L1 expression in triple-negative breast cancerMariusz Shrestha, Dong-Yu Wang, Yaacov Ben-David, et al.
Cancers|March 25, 2022
Targeting an MDM2/MYC Axis to Overcome Drug Resistance in Multiple MyelomaOmar Faruq, Davidson Zhao, Mariusz Shrestha, et al.
Scientific Reports|October 30, 2025
Targeting of SKP2 to combat drug resistance in multiple myelomaOmar Faruq, Jane Ngo, Deepak Iyer, et al.
The Journal of Molecular Diagnostics : JMD|March 23, 2023
Improving RNA Fusion Call Confidence and Reliability in Molecular Diagnostic TestingMariusz Shrestha, Sasha Blay, Sydney Liang, et al.
Trends in Cancer|November 10, 2017
Mitochondrial OXPHOS Induced by RB1 Deficiency in Breast Cancer: Implications for Anabolic Metabolism, Stemness, and MetastasisEldad Zacksenhaus, Mariusz Shrestha, Jeff C Liu, et al.
Molecular & Cellular Oncology|September 26, 2018
CDC25 as a common therapeutic target for triple-negative breast cancer - the challenges aheadEldad Zacksenhaus, Jeff C Liu, Letizia Granieri, et al.
Cancers|November 25, 2023
Thinking (Metastasis) outside the (Primary Tumor) BoxZhe Jiang, Young-Jun Ju, Amjad Ali, et al.
Cell Reports|April 5, 2018
Identification of CDC25 as a Common Therapeutic Target for Triple-Negative Breast CancerJeff C Liu, Letizia Granieri, Mariusz Shrestha, et al.
The Journal of Clinical Investigation|August 30, 2016
RB1 deficiency in triple-negative breast cancer induces mitochondrial protein translationRobert A Jones, Tyler J Robinson, Jeff C Liu, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Clinical Epigenetics|April 10, 2026
Deciphering epigenetic crosstalk in multiple myeloma pathogenesis and treatmentShamila D Alipoor, Mariusz Shrestha, Aijun Liu, et al.
Oncogenesis|May 25, 2023
CDK4/6 inhibitors and the pRB-E2F1 axis suppress PVR and PD-L1 expression in triple-negative breast cancerMariusz Shrestha, Dong-Yu Wang, Yaacov Ben-David, et al.
Cancers|March 25, 2022
Targeting an MDM2/MYC Axis to Overcome Drug Resistance in Multiple MyelomaOmar Faruq, Davidson Zhao, Mariusz Shrestha, et al.
Scientific Reports|October 30, 2025
Targeting of SKP2 to combat drug resistance in multiple myelomaOmar Faruq, Jane Ngo, Deepak Iyer, et al.
The Journal of Molecular Diagnostics : JMD|March 23, 2023
Improving RNA Fusion Call Confidence and Reliability in Molecular Diagnostic TestingMariusz Shrestha, Sasha Blay, Sydney Liang, et al.
Trends in Cancer|November 10, 2017
Mitochondrial OXPHOS Induced by RB1 Deficiency in Breast Cancer: Implications for Anabolic Metabolism, Stemness, and MetastasisEldad Zacksenhaus, Mariusz Shrestha, Jeff C Liu, et al.
Molecular & Cellular Oncology|September 26, 2018
CDC25 as a common therapeutic target for triple-negative breast cancer - the challenges aheadEldad Zacksenhaus, Jeff C Liu, Letizia Granieri, et al.
Cancers|November 25, 2023
Thinking (Metastasis) outside the (Primary Tumor) BoxZhe Jiang, Young-Jun Ju, Amjad Ali, et al.
Cell Reports|April 5, 2018
Identification of CDC25 as a Common Therapeutic Target for Triple-Negative Breast CancerJeff C Liu, Letizia Granieri, Mariusz Shrestha, et al.
The Journal of Clinical Investigation|August 30, 2016
RB1 deficiency in triple-negative breast cancer induces mitochondrial protein translationRobert A Jones, Tyler J Robinson, Jeff C Liu, et al.
Pageof 2